Literature DB >> 1574683

Retention of streptococci to defined solid surfaces in the presence of saliva secretions.

C E Christersson1, P O Glantz.   

Abstract

The initial surface retention of Streptococcus sanguis (G9B and ATCC 10556) and Streptococcus salivarius (ATCC 9758 and ATCC 13419) was examined using a well defined flow cell system. The microorganisms, known to be recovered from hard vs. soft tissue surfaces, respectively, were suspended in either Ringer solution, human parotid saliva (HPS), human submandibular and sublingual saliva (HSMSL), or mixed saliva. Microbial retention was evaluated on germanium prisms of low (20-25 mNm-1) and medium (30-35 mNm-1) critical surface tensions following distilled water rinse at 1 ml/min for 15 min. When suspended in only Ringer solution, the tested microorganisms showed patterns of generally high retention, that reflected the influence of both bacterial and substratum surface properties. However, in the saliva suspensions an overall reduction of retention was found with preferential retention to surfaces of medium critical surface tension for all bacteria. When comparing HPS and HSMSL as the suspending medium, a statistically significant observation was that smaller numbers of retained bacteria were recorded in the presence of HSMSL. The most frequently observed relationship between the tested salivas and numbers of retained cells was HSMSL less than MIXED less than HPS.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1574683     DOI: 10.1111/j.1600-0722.1992.tb01719.x

Source DB:  PubMed          Journal:  Scand J Dent Res        ISSN: 0029-845X


  2 in total

Review 1.  The oral cavity--a key system to understand substratum-dependent bioadhesion on solid surfaces in man.

Authors:  Christian Hannig; Matthias Hannig
Journal:  Clin Oral Investig       Date:  2009-01-10       Impact factor: 3.573

2.  Susceptibility of planktonic versus attached Streptococcus sanguinis cells to chlorhexidine.

Authors:  Eva-Maria Decker; R Weiger; C von Ohle; I Wiech; M Brecx
Journal:  Clin Oral Investig       Date:  2003-04-18       Impact factor: 3.573

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.